Health Talk | To combat dengue menace, a promising vaccine candidate enters phase three trials in India

Health Talk | To combat dengue menace, a promising vaccine candidate enters phase three trials in India

Earlier this month, there were reports that the third phase of clinical trials of a dengue vaccine candidate will soon start across the country. PREMIUM (Representational Image) According to the company, the clinical studies showed the vaccine to be safe and well tolerated (AFP) One of the Indian Council of Medical Research (ICMR) research institutes, …

Read more

Focus on Quality Over Quantity of Life

Focus on Quality Over Quantity of Life

This transcript has been edited for clarity.  Hello. I’m Dr Maurie Markman, from City of Hope. I wanted to briefly discuss what I consider to be not only a critically important trial but also a representative of an incredibly important, underrepresented type of trial as we move forward in the oncology arena. I cannot overstate …

Read more

Study reveals risk-reducing mastectomy (RRM) may reduce breast cancer mortality

Study reveals risk-reducing mastectomy (RRM) may reduce breast cancer mortality

ANI | Updated: Feb 19, 2024 04:58 IST Washington DC [US], February 19 (ANI): A study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing and researchers from the Familial Breast Cancer Research Unit at Women’s College Hospital discovered that risk-reducing mastectomies (RRM) in women with a BRCA1 or BRCA2 genetic variant …

Read more

Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines

Redirecting antibody responses from egg-adapted epitopes following repeat vaccination with recombinant or cell culture-based versus egg-based influenza vaccines

Influenza vaccines and vaccine viruses used during the 2018−2019 and 2019−2020 study seasons This study was a randomized, open-label trial conducted in the United States during the Northern Hemisphere 2018−2019 (Year 1, n = 723) and 2019−2020 (Year 2, n = 684) influenza seasons (Fig. 1). In year 1, HCP were randomized to receive one of four influenza vaccines: ccIIV4 …

Read more

Walking Fast May Help Prevent Type 2 Diabetes

Walking Fast May Help Prevent Type 2 Diabetes

Walking is a simple, cost-free form of exercise that benefits physical, social, and mental health in many ways. Several clinical trials have shown that walking regularly is associated with a lower risk for cardiovascular events and all-cause mortality, and having a higher daily step count is linked to a decreased risk for premature death. Walking …

Read more

Is Migraine Really a Female Disorder?

Is Migraine Really a Female Disorder?

BARCELONA, Spain — Migraine is widely considered a predominantly female disorder. Its frequency, duration, and severity tend to be higher in women, and women are also more likely than men to receive a migraine diagnosis. However, gender expectations, differences in the likelihood of self-reporting, and problems with how migraine is classified make it difficult to …

Read more

Sleeping Beats Sitting? What a New Study Means for Your Patients

Sleeping Beats Sitting? What a New Study Means for Your Patients

Sit less, move more. Or stand more. Or sleep more. Replacing 30 minutes of sitting a day with equal time standing or even sleeping could improve obesity markers like body weight and waist circumference, according to a new cross-sectional study investigating the impact of movement behavior on cardiometabolic health.  The findings suggest that, while higher-intensity …

Read more

ORBITA-2 Saves Interventional Cardiology, Questions Guidance

ORBITA-2 Saves Interventional Cardiology, Questions Guidance

When Christopher Rajkumar, MD, presented the positive results of ORBITA-2, the second placebo-controlled trial of percutaneous coronary intervention (PCI) in stable angina, you could almost feel the relief of cardiologists at the American Heart Association meeting. All is right again. Thank goodness. The first ORBITA trial stunned our community when it showed that PCI compared …

Read more